ArticleIndian journal of ophthalmology2021

Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab.

Lalit Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.